Gyre Therapeutics (GYRE) Cash & Equivalents (2009 - 2026)
Gyre Therapeutics' Cash & Equivalents came in at $43.3 million for Q2 2026, up 18.6% from $36.5 million a year earlier and up 15.5% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Gyre Therapeutics' Cash & Equivalents was $49.19 million, up 316.4% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 10.1% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $11.81 million in FY2024 (-64.7%), $33.51 million in FY2023 (+33.1%), $25.18 million in FY2022 (-43.2%) and $44.35 million in FY2021 (+46.1%).
- The five-year range for quarterly Cash & Equivalents is $2.23 million (Q3 2023) to $75.4 million (Q2 2022).
- Year-over-year, Cash & Equivalents has increased for five consecutive quarters, with growth averaging 158.1% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2024 (growth of 613.6%), and the weakest in Q2 2023 (a decline of 90.8%).
- Business Quant data shows GYRE's Cash & Equivalents at $37.5 million (Q1 2026), $49.19 million (Q4 2025) and $40.4 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Gyre Therapeutics | 487.81 Mn | 295.13 Mn | 30.99 Mn | 41.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 41.64 Mn |
| Jun 30, 2026 | 43.30 Mn |
| Mar 31, 2026 | 37.50 Mn |
| Dec 31, 2025 | 49.19 Mn |
| Sep 30, 2025 | 40.40 Mn |
| Jun 30, 2025 | 36.50 Mn |
| Mar 31, 2025 | 15.05 Mn |
| Dec 31, 2024 | 11.81 Mn |
| Sep 30, 2024 | 15.90 Mn |
| Jun 30, 2024 | 16.10 Mn |
| Mar 31, 2024 | 29.80 Mn |
| Dec 31, 2023 | 33.51 Mn |
| Sep 30, 2023 | 2.23 Mn |
| Jun 30, 2023 | 6.92 Mn |
| Mar 31, 2023 | 8.10 Mn |
| Dec 31, 2022 | 25.18 Mn |
| Sep 30, 2022 | 23.10 Mn |
| Jun 30, 2022 | 75.40 Mn |
| Mar 31, 2022 | 34.82 Mn |
| Dec 31, 2021 | 44.35 Mn |
API Access
Gyre Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();